PFE250417P00032000 Option on Pfizer Inc

PFE Stock  USD 25.21  0.34  1.33%   
Pfizer's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.46 with a put-to-call open interest ratio of 0.77 over 65 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on June 20th 2025. The total put volume is at 4.1 K, with calls trading at the volume of 13.3 K. This yields a 0.31 put-to-call volume ratio.

Open Interest Against June 20th 2025 Option Contracts

The chart above shows Pfizer's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Pfizer's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Pfizer's option, there is no secondary market available for investors to trade.

Pfizer Maximum Pain Price Across 2025-06-20 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Pfizer close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Pfizer's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Pfizer

Analyzing Pfizer's in-the-money options over time can help investors to take a profitable long position in Pfizer regardless of its overall volatility. This is especially true when Pfizer's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Pfizer's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Pfizer's stock while costing only a fraction of its price.
Pfizer's stock options are financial instruments that give investors the right to buy or sell shares of Pfizer Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Pfizer stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Pfizer's stock price goes up or down, the stock options follow.
At present, Pfizer's Sale Purchase Of Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 920.9 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 107.7 B.

Pfizer Inc In The Money Call Balance

When Pfizer's strike price is surpassing the current stock price, the option contract against Pfizer Inc stock is said to be in the money. When it comes to buying Pfizer's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Pfizer Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Pfizer Current Options Market Mood

Pfizer's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Pfizer Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Pfizer's options investors are not very successful. Pfizer's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Pfizer contract

Base on the Rule 16, the options market is currently suggesting that Pfizer Inc will have an average daily up or down price movement of about 0.0288% per day over the life of the 2025-06-20 option contract. With Pfizer trading at USD 25.21, that is roughly USD 0.007248. If you think that the market is fully incorporating Pfizer's daily price movement you should consider buying Pfizer Inc options at the current volatility level of 0.46%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Pfizer options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Pfizer calls. Remember, the seller must deliver Pfizer Inc stock to the call owner when a call is exercised.

Pfizer Option Chain

When Pfizer's strike price is surpassing the current stock price, the option contract against Pfizer Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Pfizer's option chain is a display of a range of information that helps investors for ways to trade options on Pfizer. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Pfizer. It also shows strike prices and maturity days for a Pfizer against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
PFE250620C00045000524245.00.0 - 0.040.03Out
Call
PFE250620C000440001744.00.0 - 1.270.02Out
Call
PFE250620C0004300011643.00.0 - 2.00.02Out
Call
PFE250620C00042000369642.00.01 - 0.080.01Out
Call
PFE250620C000410004441.00.0 - 1.270.03Out
Call
PFE250620C000400002198740.00.02 - 0.030.03Out
Call
PFE250620C00039000939.00.0 - 0.30.02Out
Call
PFE250620C00038000238.00.0 - 0.10.02Out
Call
PFE250620C00037000778537.00.02 - 0.050.02Out
Call
PFE250620C000360008736.00.0 - 0.10.02Out
Call
PFE250620C000350003629435.00.02 - 0.040.03Out
Call
PFE250620C00034000323834.00.01 - 0.10.04Out
Call
PFE250620C00033000156133.00.03 - 0.050.04Out
Call
PFE250620C000320001035432.00.03 - 0.070.05Out
Call
PFE250620C00031000466431.00.06 - 0.090.08Out
Call
PFE250620C000300005138730.00.11 - 0.120.11Out
Call
PFE250620C000290001467229.00.16 - 0.180.17Out
Call
PFE250620C000280004683128.00.28 - 0.290.27Out
Call
PFE250620C000270001974627.00.45 - 0.490.49Out
Call
PFE250620C000260001966326.00.77 - 0.810.8Out
Call
PFE250620C000250002463025.01.24 - 1.281.26In
Call
PFE250620C00024000501124.01.85 - 1.91.89In
Call
PFE250620C00023000203823.02.6 - 2.852.75In
Call
PFE250620C00022000186322.03.45 - 3.553.6In
Call
PFE250620C000210007921.03.65 - 5.155.0In
Call
PFE250620C00020000204420.05.35 - 5.455.4In
Call
PFE250620C000190001819.05.35 - 7.36.58In
Call
PFE250620C000180003318.07.3 - 7.47.76In
Call
PFE250620C000160001016.09.15 - 10.010.45In
Call
PFE250620C000150005715.010.25 - 10.3511.19In
Call
PFE250620C00014000114.011.25 - 11.3512.1In
Call
PFE250620C000130001813.011.4 - 12.3513.3In
 Put
PFE250620P00045000145.019.9 - 20.016.25In
 Put
PFE250620P00044000044.018.9 - 19.918.9In
 Put
PFE250620P00043000043.017.8 - 18.017.8In
 Put
PFE250620P00042000042.015.95 - 17.9512.02In
 Put
PFE250620P00041000041.015.9 - 16.615.9In
 Put
PFE250620P000400008040.014.9 - 15.514.5In
 Put
PFE250620P00039000039.013.9 - 14.313.9In
 Put
PFE250620P00038000038.012.05 - 13.912.05In
 Put
PFE250620P0003700027537.011.95 - 12.0510.65In
 Put
PFE250620P00036000236.010.9 - 11.059.45In
 Put
PFE250620P0003500096035.09.95 - 10.059.74In
 Put
PFE250620P0003400010134.08.65 - 9.458.34In
 Put
PFE250620P0003300040633.07.1 - 8.18.1In
 Put
PFE250620P00032000751232.07.0 - 7.16.95In
 Put
PFE250620P0003100033631.06.0 - 6.75.92In
 Put
PFE250620P000300001374530.05.05 - 5.154.95In
 Put
PFE250620P00029000120229.04.1 - 4.23.95In
 Put
PFE250620P000280002649228.03.2 - 3.33.12In
 Put
PFE250620P00027000786627.02.29 - 2.472.43In
 Put
PFE250620P000260001785026.01.7 - 1.741.73In
 Put
PFE250620P000250006017125.01.08 - 1.161.14Out
 Put
PFE250620P00024000945624.00.71 - 0.750.72Out
 Put
PFE250620P000230002896523.00.43 - 0.460.43Out
 Put
PFE250620P00022000937322.00.26 - 0.290.27Out
 Put
PFE250620P00021000469621.00.16 - 0.190.19Out
 Put
PFE250620P000200001680320.00.11 - 0.130.12Out
 Put
PFE250620P0001900030519.00.08 - 0.110.07Out
 Put
PFE250620P00018000682318.00.02 - 0.120.06Out
 Put
PFE250620P000170001317.00.01 - 0.130.07Out
 Put
PFE250620P0001600011416.00.02 - 0.090.03Out
 Put
PFE250620P00015000438115.00.02 - 0.030.03Out
 Put
PFE250620P00014000214.00.0 - 0.050.03Out
 Put
PFE250620P0001300075513.00.01 - 0.020.02Out

Pfizer Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Pfizer Total Stockholder Equity

Total Stockholder Equity

48.18 Billion

At present, Pfizer's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Pfizer Corporate Directors

Helen HobbsIndependent DirectorProfile
Shantanu NarayenLead Independent DirectorProfile
James SmithIndependent DirectorProfile
Susan DesmondHellmannIndependent DirectorProfile
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Dividend Share
1.68
Earnings Share
1.41
Revenue Per Share
11.234
Quarterly Revenue Growth
0.219
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.